Skip to main content
Premium Trial:

Request an Annual Quote

Unleashed Informatics to Collaborate with Zhejiang University to Expand BIND Interaction Viewer

NEW YORK, May 26 (GenomeWeb News) - Unleashed Informatics and the College of Life Sciences at Zhejiang University in China will collaborate on Biomolecular Interaction Network Database software development projects, the company said today.

 

The projects aim to build and expand the BIND Interaction Viewer to enable researchers to combine and represent physical and predicted molecular interactions.

 

BIND is a database of full descriptions of molecular interactions, complexes, and pathways. Its Interaction Viewer is a proprietary software system that visualizes and analyzes molecular interactions, complexes, and pathways. Unleashed Informatics holds exclusive rights to commercially distribute the Interaction Viewer.

 

The enhanced viewer will be integrated with Unleashed Informatics' BINDPlus, a subscription biomolecular database containing physical, associated, and predicted biomolecular interactions spanning genomics, proteomics, and metabolomics.

 

Associate Professor Chen Xin, the former manager with the BIND curation operation in Singapore, will lead the collaboration.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.